D
escription of the behavioral, environmental, and genetic factors in patients with acute myocardial infarction (AMI) underscores our current understanding of the causal relationship between patient-and population-specific exposures, or risk factors, and clinical outcomes. [1] [2] [3] [4] Patients with AMI represent a distinct, highly select subgroup of the general population. Changes in the extent and distribution of specific clinical, demographic, and biochemical factors over time in patients with AMI provide insight into the overall burden of disease in individuals at the highest risk for AMI. The latter is of relevance from demographic and public health perspectives, given the increasing number of individuals in the general population at risk for AMI 5 and the increasing number of survivors of AMI. 6 Finally, such studies, by revealing an increased or unchanging presence of specific risk factors, could suggest additional or missed opportunities for preventive strategies. 7, 8 In the present analysis from the American Heart Association (AHA) Get With The Guidelines Coronary Artery Disease (GWTG-CAD) program, we report the prevalences of clinical, demographic, and biochemical factors in patients presenting with AMI and the changes in those prevalences from 2003 to 2008.
Methods
The AHA GWTG-CAD Program
The mission, scope, and purpose of the AHA GWTG-CAD program have been described previously. 9, 10 Because GWTG-CAD is a quality-improvement program, hospitals are encouraged to consecutively enroll all eligible patients. The GWTG-CAD population includes all patients admitted to the hospital who were subsequently discharged with a diagnosis of AMI, unstable angina, chronic stable angina, or ischemic heart disease (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes 410-414). Each participating site is responsible for its own data collection and uploading. Data quality is monitored in a Web-based system, and reports are provided to the site to ensure completeness and accuracy of the submitted data. Data collected include patient demographics, medical history, symptoms on arrival, results of laboratory testing, in-hospital treatment and events, discharge treatment and counseling, and patient disposition. The de-identification of patients occurs at this level. All participating institutions were required to comply with local regulatory and privacy guidelines and to submit the GWTG-CAD protocol for review and approval by their institutional review boards. Because data were used primarily at the local site for quality improvement, sites were granted a waiver of informed consent under the common rule. The Duke Clinical Research Institute (Durham, NC) serves as the data analysis center and has institutional review board approval to analyze the aggregate de-identified data for research purposes.
Patient Population
The GWTG-CAD program began in 2000, and the length of participation of each hospital depended on the time it entered the program. Baseline data included the first 30 admissions for each participating site and served as the entry point into the study. Subsequently, participation time was calculated in calendar quarters. Quarters with <1000 admissions were excluded to obtain reliable estimates of trends over time; this necessitated exclusion of data obtained in all 4 quarters of 2000 and 2001. Therefore, all GWTG-CAD-participating hospitals enrolled from January 1, 2002, to April 2010 were eligible for analysis.
The patient sample for this study was derived from the population of patients with a first-listed diagnosis and supporting ICD-9-CM code for coronary heart disease who were admitted to hospitals participating in the AHA GWTG-CAD program. Data from January 2002 through April 2010 were reviewed. Over this interval, 282 585 patients had an ICD-9-CM-consistent diagnosis of AMI (ICD-9-410). Excluded were records created before 2003 (n=23 024), records created after 2008 because of administrative changes in the GWTG program (n=16 396), patients with heart failure with CAD (n=36 574), patients without an AMI (n=66 940), and patients with an unspecified AMI (n=1529). The final study sample consisted of 138 122 patients (from 398 sites) admitted from January 1, 2003, to December 31, 2008 . Patients subsequently were categorized by the electrocardiogram pattern on admission: specifically, those with STsegment-elevation myocardial infarction (STEMI; n=44 172) or a new or presumably new left bundle-branch block pattern and those without ST-segment elevation (NSTEMI; n=92 950).
Data and Statistical Analysis
Data are presented as means ± standard deviations or medians and interquartile ranges (IQRs) for continuous variables and as percentages for categorical variables for the overall data set and separately for the STEMI A variable was not included in the model as an independent variable when that variable was the dependent variable. From these models, unadjusted and adjusted odds ratios (ORs) for the change in prevalence of each analyzed risk factor per quarter-calendar-year increment were estimated, and results were reported as the cumulative OR for the 6 years of the study by exponentiating the OR per 1-year change to the power of 6. Because there was evidence for statistical interaction-that is, P<0.05-in several of the models (male sex, diabetes mellitus, hypertension) when the interaction term (time9STEMI/NSTEMI) was added to the above list of confounders, results are reported separately for each stratum.
Sensitivity Analysis
Because sites both "dropped in" and "dropped out" over the time interval of the study, a sensitivity analysis was performed on only those sites that contributed at least All analyses were performed in SAS version 9.2 (SAS Institute, Cary, NC). All significance tests were 2 sided, and P values <0.05 were considered statistically significant. Given the number of comparisons performed in this study, the lack of adjustment for such multiple comparisons, and the large overall sample size, a more conservative definition of statistical significance is suggested when P<0.001.
Results
Demographic Characteristics of Overall AMI Patient Population Over Time: Univariate Analysis
As seen in Table 1 , the change in age distribution over time for the total sample was of borderline statistical significance (2003 median/IQR, 67/22 years; 2008 median/IQR, 66/22 years; P=0.0535). However, there was a significant increase over time in the relative proportion of patients between the ages of 45 and 65 years (P<0.0001), and the relative proportion of patients ≥65 years of age decreased (P<0.0001). There was a significant change in the sex ratio (males per 100 females) from 2003 to 2008, with an increasing proportion of females in later years ( Figure 1A and 1B).
The distribution of racial/ethnic groups within the overall sample exhibited a significant change over time (Table 1) , with a decreasing proportion of Hispanics within the sample, an increasing proportion of African Americans, and a relatively constant proportion of white patients. There was also a significant change in the distribution of insurance status over time ( 
<0.0001
Medical history panel missing stabilize from 2006 to 2008 (P for trend <0.0001). However, the prevalence of "low" HDL (men, <40 mg/dL; women, <50 mg/dL) increased from 40.1% in 2003 to 47.5% in 2008 (P for trend <0.0001). There was a significant increase in the proportion of patients with NSTEMI over time ( Table 1) . Overall trends in the prevalence of key risk factors are depicted in Figure 2 . There were notable differences between patients with NSTEMI and patients with STEMI (Table 2) . In general, patients with NSTEMI were significantly more likely to be older and female and to have a greater burden of clinical risk factorsfor example, hypertension, diabetes mellitus, and prior myocardial infarction. Conversely, patients with STEMI were more likely to be younger, male, and active smokers and to have a higher prevalence of biochemical risk factors-for example, "low" HDL, "high" LDL, and triglycerides >150 mg/dL.
Demographic, Clinical, and Biochemical Characteristics of Patients With STEMI Over Time: Univariate Analysis
As seen in Table 3 , in patients with STEMI, the median/IQR ages in 2003 and 2008 were, respectively, 63/22 years and 61/20 years (P for trend <0.0001), and the proportion of patients ≥65 years of age decreased (P<0.0001). The proportion of patients between 45 and 65 years of age remained stable over time. The sex ratio (number of males/100 females) increased over time (P=0.0002). There was a slight but significant decrease in the proportion of non-Hispanic whites (P<0.0001) and a decrease in the proportion of Hispanic patients over time (2003, 7 
Sensitivity Analysis
Sensitivity analysis on the core data set (cf. Methods) indicated excellent quantitative and qualitative agreement with the overall data set findings. Specifically, the frequency of missing medical history data was 6.35% in the core data set and 5.91% in the overall data set. Median age (67 years) and mean age (66.3 years) in the core data set were identical to the overall data set, and the trends over time were directionally similar. Sex ratios were numerically similar in the core and overall data sets, although the sex ratio trend in the core data set failed to reach statistical significance. Numerically and directionally similar trends in the prevalences of diabetes mellitus, hypertension, and hyperlipidemia were also in close agreement, as were the trends in obesity prevalence and "low" HDL.
Trends in Clinical Characteristics and Risk Factors of STEMI Patient Population: Multivariable Analysis
After adjustment for multiple potential confounding variables, including other risk factors (Table 5) , the increase over time in the proportion of patients between 45 and 65 years of age was significant, along with increases in the prevalences of obesity and "low" HDL. However, there were significant decreases over time in the prevalences of hypertension, diabetes mellitus, prior AMI, and current/recent smoking, as well as decreases in the prevalences of "high" LDL and triglycerides >150 mg/dL.
Trends in Clinical Characteristics and Risk Factors of NSTEMI Patient Population: Multivariable Analysis
After adjustment for multiple confounding variables, including other risk factors (Table 6) , there were significant increases over time in the proportion of patients between 45 and 65 years of age, whereas the proportion of "younger" patients (≤45 years) decreased. The proportion of women increased over time, as did the proportion of Hispanic patients. The prevalence of diabetes mellitus decreased over time, whereas the prevalence of obesity increased. The prevalence of "low" HDL increased significantly, whereas the prevalence of "high" LDL decreased over time.
Sensitivity Analysis
In general, there was quantitative and qualitative agreement between the core data sets and the overall stratum-specific analyses. In the STEMI group, the analyses differed only in the magnitude of the coefficient for the decrease in hypertension prevalence, whereas in the NSTEMI group, the analyses differed only in the magnitude of the coefficients for the changes in sex ratio and hypertension prevalence.
Discussion
The present analysis of the clinical, demographic, and biochemical characteristics of patients with AMI admitted to hospitals participating in the AHA GWTG-CAD qualityimprovement initiative from 2003 to 2008 suggests that the cumulative risk factor burden in patients with AMI remained substantial. Favorable decreases in the prevalences of several "classic" risk factors over this interval were offset by increases in the prevalences of obesity and "low" HDL and suggest that metabolic derangements are likely to remain important contributors to overall risk factor burden. The present observations are in agreement with previous reports from dedicated registries of patients with AMI 12,13 and population-based studies, 14,15 which described an increase in the NSTEMI/STEMI ratio over time. Although some of this increase has been attributed to a change in the diagnostic criteria for AMI around 2000, 16 not all of the increase in the proportion of NSTEMI can be attributed to this transition. 15, 17, 18 All patients in the present analysis were enrolled from 2003 forward and thus were ascertained with standardized post-transition criteria. Our data are also in agreement with prior studies reporting the risk factor burden in patients with AMI. [1] [2] [3] Despite high prevalence of a history of hyperlipidemia and hypertension, the recorded numerical values for admission blood pressure (data not shown), LDL, and total cholesterol in the GWTG-CAD registry are consistent with the increasing extent of antihypertensive and lipid-lowering treatment in the general US population. 19, 20 The present data mirror previously reported magnitudes and trends in the prevalence of obesity in AMI registries 12, 13 Continued and population-based studies. 14, 19, 21 However, the increase in the prevalence of obesity in the general population might not be continuing at the same rate in more recent years. 22, 23 The small numerical, albeit statistically significant, increase in the prevalence of BMI ≥30 kg/m 2 in the present sample of patients with AMI is in agreement with these latter reports.
The clinical relevance of an overall prevalence of obesity of 30% in this sample of patients with AMI should not be overlooked, given the strong associations among obesity, diabetes mellitus, hypertension, and dyslipidemia. The observed downward trend in the unadjusted and adjusted prevalences of diabetes mellitus in our study remains unexplained and is at odds with prior observations in patients with AMI, 12, 13 although it is numerically consistent with a more recent nested cohort population-based study. 15 The present data should be viewed in the broader clinical context of, on average, a prevalence of diabetes mellitus of 30% in patients with AMI, 6, 14, 21 depending on the diagnostic criteria used. The overall prevalence of diabetes mellitus was higher in patients with NSTEMI, whereas the magnitude of change in the prevalence of diabetes mellitus in patients with NSTEMI was less than that observed in patients with STEMI, which underscores the importance of stratum-specific analysis. The additional information presented herein about a significant trend for the increase in prevalence of "low" HDL is in agreement with previous reports of an increase in prevalence of metabolic derangements in patients with AMI 24 as well as in the adult US population. 25 
Implications of Changes in Demographic Composition of the Current AMI Sample
The changes in the age and sex distributions of the GWTG-CAD AMI population from 2003 to 2008, as shown in Figure 1A and 1B, parallel the changes seen in the US population in the first decade of this century, 5 with the fastest rate of growth noted in the 45-to 64-year age group. 5 This group comprises the initial cohorts of the "Baby Boom" generation as they enter the age range in which the risk of AMI begins to increase steeply. 6 The increased prevalence of poor cardiovascular health behaviors and health factors in middle (40 to 64 years) and older (≥65 years) age groups in the US population over the identical time period as the present study provides additional insight into the correspondence between specific characteristics in patients with AMI and adults of similar age in the general population. 26 In a separate report from the National Health and Nutrition Examination Survey encompassing the years 1988-2010, the prevalence of smoking decreased, and the prevalences of desirable levels of untreated blood pressure and total cholesterol were unchanged, whereas the prevalences of desirable levels of BMI and fasting glucose decreased, 27 indicative of a persistently elevated risk factor burden in the general US population. The public health implications and relevance of these observations and correlations are clear. [28] [29] [30] The prevalence of risk factors, and their trends over time, in patients with AMI point to additional need for risk factor intervention at the population level. 31, 32 The present data from 2003 to 2008, however, only begin to suggest a population momentum effect resulting from the age cohorts comprising the "Baby Boom" generation. Even static levels of age-specific prevalences, when multiplied by the increasing number of subjects at risk due to population momentum, will result in an increase in the overall risk factor burden.
Limitations
The limitations of the present analysis relate chiefly to the use of registry data. It is recognized that there are many potential sources of selection bias in any registry and that the patients in the AHA GWTG-CAD registry might not be representative of all patients with AMI. Similarities to, as well as differences from, the published literature have been noted. Participation in the GWTG-CAD quality-improvement program is voluntary, and as such, the program is likely to include higherperforming hospitals. However, such potential selection bias is unlikely to affect the type, or number, of patient(s) presenting with an AMI, nor are the prevalences of underlying risk factors likely to be affected. Data could be influenced by both drop-in and drop-out of participating hospitals. Sensitivity analysis limited to those hospitals participating in each year revealed substantially similar trends and associations among key risk factors, with few exceptions. Participation in the GWTG-CAD program calls for consecutive enrollment of patients, as is appropriate for performance (per Centers for Medicare and Medicaid Services) and quality-improvement (per Joint Commission) initiatives. Compliance, or the number of patients enrolled per site per year, did not change over time among core sites (P for trend=0.17). The analysis of data collected over 6 years from >100 000 patients is likely to be more representative of "real-world" patients with AMI than an analysis from any one region or in any one year would be. The GWTG-CAD program includes sites from all regions of the United States and includes academically affiliated as well as community-based hospitals. Patients in the GWTG-Stroke performance-improvement program, a group not substantially dissimilar from patients with AMI with regard to cardiovascular risk factors, have been shown to be similar to patients in non-GWTG-participating centers. 33 However, at the present time, there are no comparable studies in patients with CAD/ AMI. Changes in professional and societal awareness of the presence and importance of sex-specific differences in cardiovascular disease at the time of this study 34 could have had an important, albeit unquantifiable, effect on our findings. However, a recent study failed to identify differences in the time to hospital presentation among women with AMI after a national awareness campaign. 35 Data were collected by chart review and are dependent on the accuracy and completion of documentation and abstraction. All data are entered at the site by highly trained individuals with experience in data entry. The GWTG database features carefully defined data entries, standardized diagnostic criteria throughout, and regular quality assessment. Importantly, the GWTG database includes only patients with confirmed AMI diagnosis at discharge and avoids many of the sources of information bias when the diagnosis is based on admission characteristics. These data and inferences from the data could, however, be limited by potential bias resulting from the inability of disadvantaged and minority groups to access medical care. Such patients are not, by definition, included in the GWTG-CAD data set and cannot be evaluated. The inferences with regard to changes in the prevalence of risk factors suggested by these data apply to the overall patient population.
The magnitudes of the reported main outcome measures of association-the OR for a change in prevalence of a given risk factor per 1 year-were small and initially suggested little clinically significant change from year to year, despite their statistical significance. We chose to report the cumulative OR for the change in prevalence of characteristics over the 6-year observation period in an effort to underscore their clinical significance. Statistical methodology dictates that the (adjusted) ORs must be interpreted in the context of all other covariates being fixed. From clinical and epidemiological perspectives, multiple covariates are not infrequently identified in the same individual-for example, diabetes mellitus, hypertension, and obesity. Statistical attempts to "isolate" changes in one of several highly associated variables might result in unstable or misleading estimates of a true association. It is acknowledged that the use of an OR as an approximation of relative risk, or risk ratio, is problematic when prevalence is high. The majority of the characteristics and risk factors reported here have a high prevalence, and calculation of prevalence ratios and their changes would be more appropriate. 36 However, qualitative inferences from this study remain valid.
In conclusion, the present analysis, based on >100 000 patients with AMI from 2003 to 2008, indicates that there were clinically and statistically significant changes over time in the risk factors and characteristics assessed. Increases in the prevalence of women, NSTEMI, and patients 45 to 65 years of age, when viewed from an epidemiological perspective, have important implications for the identification of further opportunities for risk factor modification. Continued increases in the prevalence of obesity and low HDL over the next decade, along with persistently high prevalences of hypertension and diabetes mellitus, particularly in the growing segment of patients with NSTEMI, could offset the beneficial clinical effects of decreasing trends in other risk factors and could result in higher disease burden and post-AMI morbidity in AMI survivors.
